NCT02092571

A Pharmacokinetic Study to Evaluate the Bioequivalence of 2 Progesterone Vaginal Rings in Postmenopausal Women

An Open-Label, Single-Dose, Randomized, 2-Treatment, 2-Period Crossover Pharmacokinetic Study to Evaluate the Bioequivalence of 2 Progesterone Vaginal Rings 20% (w/w) in Postmenopausal Women

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 56 (actual)
• Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. · Industry
• Sex: Female
• Age: 40 Years – 70 Years
• Healthy volunteers: Accepted

Summary

A study to assess the pharmacokinetics of 2 progesterone vaginal rings in postmenopausal women

Conditions

• Pharmacokinetics

Interventions

Type	Name	Description
DRUG	Progesterone vaginal ring,	Participants will be randomized to receive treatments in 1 of 2 treatment sequences (AB or BA)

Timeline

• Start date: 2014-02-01
• Primary completion: 2014-07-01
• Completion: 2014-08-01
• First posted: 2014-03-20
• Last updated: 2021-11-09

Locations

1 site across 1 country: United States